{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:31:23Z","timestamp":1783488683106,"version":"3.55.0"},"reference-count":15,"publisher":"Japan Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1507\/endocrj.ej16-0199","type":"journal-article","created":{"date-parts":[[2016,12,26]],"date-time":"2016-12-26T22:10:05Z","timestamp":1482790205000},"page":"283-289","source":"Crossref","is-referenced-by-count":40,"title":["Hypertension is a characteristic complication of X-linked hypophosphatemia"],"prefix":"10.1507","volume":"64","author":[{"given":"Yoshie","family":"Nakamura","sequence":"first","affiliation":[{"name":"Division of Genetic Research, Tokyo Metropolitan Children&rsquo;s Medical Center, Tokyo 183-8561, Japan"},{"name":"Division of Endocrinology and Metabolism, Tokyo Metropolitan Children&rsquo;s Medical Center, Tokyo 183-8561, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Takagi","sequence":"additional","affiliation":[{"name":"Division of Pediatrics, Keio University School of Medicine, Tokyo 160-8582, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryojun","family":"Takeda","sequence":"additional","affiliation":[{"name":"Division of Medical Genetics, Tokyo Metropolitan Children&rsquo;s Medical Center, Tokyo 183-8561, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Miyai","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Tokyo Metropolitan Children&rsquo;s Medical Center, Tokyo 183-8561, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Division of Genetic Research, Tokyo Metropolitan Children&rsquo;s Medical Center, Tokyo 183-8561, Japan"},{"name":"Division of Endocrinology and Metabolism, Tokyo Metropolitan Children&rsquo;s Medical Center, Tokyo 183-8561, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Beck-Nielsen SS, Brock-Jacobsen B, Gram J, Brixen K, Jensen TK (2009) Incidence and prevalence of nutritional and hereditary rickets in southern Denmark. <i>Eur J Endocrinol<\/i> 160: 491-497.","DOI":"10.1530\/EJE-08-0818"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Suzuki E, Yamada M, Ariyasu D, Izawa M, Miyamoto J, <i>et al<\/i>. (2009) Patients with Hypophosphatemic Osteomalacia Need Continuous Treatment during Adulthood. <i>Clin Pediatr Endcrinol<\/i> 18: 29-33.","DOI":"10.1297\/cpe.18.29"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Morey M, Castro-Feij&oacute;o L, Barreiro J, Cabanas P, Pombo M, <i>et al<\/i>. (2011) Genetic diagnosis of X-linked dominant Hypophosphatemic Rickets in a cohort study: tubular reabsorption of phosphate and 1,25(OH)2D serum levels are associated with PHEX mutation type. <i>BMC Med Genet<\/i> 12: 116.","DOI":"10.1186\/1471-2350-12-116"},{"key":"4","unstructured":"4. The National Health and Nutrition Survey in Japan, 2012 [Internet]. Japan: Ministry of Health, Labor and Welfare of Japan. [cited 2013 Dec 19]. Available from: http:\/\/www.mhlw.go.jp\/bunya\/kenkou\/eiyou\/dl\/h24-houkoku-05.pdf."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, <i>et al. <\/i>(2009) Revised equations for estimated GFR from serum creatinine in Japan. <i>Am J Kidney Dis<\/i> 53: 982-992.","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"6","unstructured":"6. Takeda R, Miyai K, Takagi M, Goto M, Ariyasu D, <i>et al<\/i>. (2015) Tmp\/GFR is a more useful marker than %TRP in making a clinical diagnosis of X-linked hypophosphatemic rickets caused by the PHEX gene mutation. <i>J Jpn Pediatr Soc<\/i> 119: 680-686 (In Japanese)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL (2011) A clinician&rsquo;s guide to X-linked hypophosphatemia. <i>J Bone Miner Res<\/i> 26: 1381-1388.","DOI":"10.1002\/jbmr.340"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Alon US, Monzavi R, Lilien M, Rasoulpour M, Geffner ME, <i>et al<\/i>. (2003) Hypertension in hypophosphatemic rickets--role of secondary hyperparathyroidism. <i>Pediatr Nephrol <\/i>18: 155-158.","DOI":"10.1007\/s00467-002-1044-6"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Letizia C, Ferrari P, Cotesta D, Caliumi C, Cianci R, <i>et al<\/i>. (2005) Ambulatory monitoring of blood pressure (AMBP) in patients with primary hyperparathyroidism. <i>J Hum Hypertens <\/i>19: 901-906.","DOI":"10.1038\/sj.jhh.1001907"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Holm IA, Nelson AE, Robinson BG, Mason RS, Marsh DJ, <i>et al<\/i>. (2001) Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets. <i>J Clin Endocrinol Metab<\/i> 86: 3889-3899.","DOI":"10.1210\/jcem.86.8.7761"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Cho HY, Lee BH, Kang JH, Ha IS, Cheong HI<i>, <\/i><i>et<\/i><i> al.<\/i> (2005) A clinical and molecular genetic study of hypophosphatemic rickets in children. Pediatr Res 58: 329-333.","DOI":"10.1203\/01.PDR.0000169983.40758.7B"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Beck-Nielsen SS, Brusgaard K, Rasmussen LM, Brixen K, Brock-Jacobsen B, <i>et al<\/i>. (2010) Phenotype presentation of hypophosphatemic rickets in adults. Calcif Tissue Int 87: 108-119.","DOI":"10.1007\/s00223-010-9373-0"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Imel EA, Zhang X, Ruppe MD, Weber TJ, Klausner MA, <i>et al<\/i>. (2015) Prolonged Correction of Serum Phosphorus in Adults With X-Linked Hypophosphatemia Using Monthly Doses of KRN23. <i>J Clin Endocrinol Metab<\/i> 100: 2565-2573.","DOI":"10.1210\/jc.2015-1551"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Carpenter TO, Imel EA, Ruppe MD, Weber TJ, Klausner MA, <i>et al<\/i>. (2014) Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia. <i>J Clin Invest <\/i>124: 1587-1597.","DOI":"10.1172\/JCI72829"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yuan B, Feng JQ, Bowman S, Liu Y, Blank RD, <i>et al<\/i>. (2013) Hexa-D-arginine treatment increases 7B2&bull;PC2 activity in hyp-mouse osteoblasts and rescues the HYP phenotype. <i>J Bone Miner Res<\/i> 28: 56-72.","DOI":"10.1002\/jbmr.1738"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/64\/3\/64_EJ16-0199\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T07:38:46Z","timestamp":1601278726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/64\/3\/64_EJ16-0199\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej16-0199","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}